Revolution Medicines, Inc.
RVMD
$76.87
$1.562.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 24.66% | 34.35% | 23.43% | 23.55% | 90.54% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 55.04% | 15.44% | 24.34% | 52.89% | 170.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 25.23% | 33.96% | 23.44% | 23.86% | 91.53% |
|
|
|||||
| Total Current Assets | 25.23% | 33.96% | 23.44% | 23.86% | 91.53% |
| Net Property, Plant & Equipment | 68.81% | 46.19% | 43.09% | 41.80% | 35.07% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -1.88% | -1.87% | -1.86% | -1.85% | -1.84% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 177.88% | 212.57% | 134.08% | 74.58% | -4.22% |
| Total Assets | 27.73% | 34.35% | 23.95% | 24.09% | 79.12% |
|
|
|||||
| Total Accounts Payable | 206.06% | 93.60% | 46.72% | -11.91% | -17.45% |
| Total Accrued Expenses | 90.54% | 70.42% | 85.89% | 35.64% | 54.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 94.45% | 57.08% | 58.88% | 74.68% | 45.89% |
| Total Finance Division Other Current Liabilities | 544.84% | -29.68% | -12.50% | -85.04% | 166.25% |
| Total Other Current Liabilities | 544.84% | -29.68% | -12.50% | -85.04% | 166.25% |
| Total Current Liabilities | 121.55% | 75.19% | 69.22% | 13.95% | 29.60% |
|
|
|||||
| Total Current Liabilities | 121.55% | 75.19% | 69.22% | 13.95% | 29.60% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 81.50% | 51.37% | 51.97% | 52.62% | 37.16% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3,453.03% | 4,920.59% | -22.24% | -43.96% | 81.69% |
| Total Liabilities | 233.01% | 197.59% | 57.03% | 24.45% | 34.01% |
|
|
|||||
| Common Stock & APIC | 31.95% | 35.09% | 35.14% | 35.04% | 71.16% |
| Retained Earnings | -62.27% | -58.55% | -55.64% | -52.75% | -58.09% |
| Treasury Stock & Other | -18.26% | 169.89% | 242.49% | 142.83% | 537.66% |
| Total Common Equity | 1.95% | 15.23% | 20.44% | 24.04% | 87.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.95% | 15.23% | 20.44% | 24.04% | 87.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.95% | 15.23% | 20.44% | 24.04% | 87.03% |
|
|
|||||